Offering support, education, training and networking opportunities to improve personal and professional development of HIV pharmacists and technicians

UK
Joined October 2012
We are pleased to share that HIVPA is now part of BHIVA as the BHIVA Pharmacy Special Interest Group (SIG). This marks an exciting new chapter, strengthening collaboration and supporting the continued development of pharmacy practice within HIV care.
1
2
1
310
Please note that the HIVPA social media account will be closing at the end of September. Future updates, news, and pharmacy-related content will be shared through BHIVA channels, so please make sure you follow BHIVA here @BritishHIVAssoc to stay connected.
1
19
Thank you to all our members, colleagues, and supporters for your continued engagement and support throughout this journey. We look forward to this next phase and to continuing to support excellence in HIV pharmacy practice together.
14
The BHIVA HIV Pharmacy Special Interest Group is looking for new committee members to join our team. We are currently recruiting for two key roles: Bulletin Co-Leads Education Co-Lead If you are interested in either role, please get in touch.
2
51
Education Co-Lead
The role includes contributing to advanced level and consultant level credentialling and curriculum development work with the Royal College of Pharmacy, as well as supporting the SIG’s wider educational agenda.
16
Bulletin Co-Leads
We are looking for individuals to lead the production of our twice-yearly HIV Pharmacy SIG Bulletin, which is distributed to pharmacist and pharmacy technician members. This role will also involve coordinating HIV Pharmacy SIG content for BHIVA Members’ Matters
28
HIV Pharmacy Assoc.💙 retweeted
BHIVA, @BASHH_UK and @NAT_AIDS_Trust welcome the introduction of practical guidance for fertility clinics which will remove barriers to the donation of sperm or eggs by people living with HIV to recipients, including people not living with HIV. Guidelines for the Medical and Laboratory Procurement and Use of Sperm, Egg and Embryo Donors (2025) - full details can be seen here: bit.ly/4tBuIB0 This change follows the campaign started in 2018, with BHIVA and BASHH working alongside NAT to change the law regarding gametes donation. It is a further step towards equality in healthcare for people with HIV, including same sex couples where one or both have HIV and want to have children, or to donate an egg or sperm to friends or relatives experiencing fertility issues. bhiva.org/fertility-clinics-…
2
2
340
HIV Pharmacy Assoc.💙 retweeted
We’re pleased to see the publication of the new UK Guidelines for the Medical and Laboratory Procurement and Use of Sperm, Egg and Embryo Donors, developed by representatives across ARCS, BFS, BHIVA, AND BASHH. To read the full guidelines, visit bit.ly/4tBuIB0
3
2
246
HIV Pharmacy Assoc.💙 retweeted
The REgimen optimisation: Feasibility of simplifying NucleotidE therapy in HIV/HBV confection (REFINE-B) Trial. A very small study looking at stopping tenofovir/entecavir in HIV/HBV, it looked feasible short-term (no HBV flares/viral rebound at 24 wks), but data are limited and we can’t recommend tenofovir-free ART yet. Bigger studies + inclusion in HBV cure research needed. #BHIVABASHH26
3
2
250
HIV Pharmacy Assoc.💙 retweeted
Lots of interest in the congenital syphilis 2015-24 in England overview from Helen Peters at #BHIVABASH2026 showing rising numbers. Negative screening in pregnancy and engagement with care were significant factors @BritishHIVAssoc @BASHH_UK
4
2
166
HIV Pharmacy Assoc.💙 retweeted
Victoria Pilkington estimates the potential impact of opt-out HIV testing in Primary Care if this were integrated into the NHS Health Checks programme. This has the potential to identify more people outside of ED opt-out testing, and may be more cost effective! #BHIVABASHH26
4
1
228
HIV Pharmacy Assoc.💙 retweeted
Dipti and Jess from @londonftci share the outcomes of an opt-out BBV testing programme in Primary Care in Croydon. With proper staff training, meaningful information dissemination and the creation of clear, safe pathways they demonstrate how success can be achieved with this strategy. The pilot found: - a low decliner rate - successes in linkage to care and re-engagement - higher rates of BBV positivity than the local ED opt-out testing - a greater awareness of BBV in Primary Care as a result of the pilot #BHIVABASHH26
5
2
222
HIV Pharmacy Assoc.💙 retweeted
Stephanie Katier describes the PrEP service gaps which exist as a barrier to achieving global HIV elimination targets, and how utilisation of pharmacists may help bridge this. #BHIVABASHH26
4
3
294
HIV Pharmacy Assoc.💙 retweeted
Hamish Mohammed from @UKHSA explores the early uptake of DoxyPEP & the 4CMenB vaccine among a gender-diverse population who have sex with men. #BHIVABASHH26
3
4
272
HIV Pharmacy Assoc.💙 retweeted
Is it time that we review the HIV prevalence banding that guides local testing recommendations? Tamara Djuretic from @UKHSA proposes these key considerations.. #BHIVABASHH26
3
3
233
HIV Pharmacy Assoc.💙 retweeted
Martyn Wood explores the impact of the introduction of doxyPEP on gonorrhoea susceptibility. - Ciprofloxacin and tetracycline resistance increased after the introduction of doxyPEP - No differences by gender or sexuality - No differences by anatomical site - Pre-doxyPEP levels lower than national average, post-doxyPEP levels in line with national average - No conclusions can yet be drawn from this....#BHIVABASHH26
4
6
368
HIV Pharmacy Assoc.💙 retweeted
In the oral session 1 Nigel Field from @ucl explores the insights from the 2024 Natsal data for HIV and chlamydia testing from 2010-2024. Although the data are embargoed for SoMe sharing, we can conclude...👇🏾#BHIVABASHH26
3
1
180
HIV Pharmacy Assoc.💙 retweeted
Powerful session from Grace Sumner at #BHIVABASHH26 on the future of inclusion • “STIs and BBVs don’t discriminate” • Who is not in the room and why? • Guidelines don’t always reflect lived realities. • Let communities lead, not just be included. Community-led knowledge is still too often excluded from research, policy, and service design. If we’re serious about equity, we need to be willing to have uncomfortable conversations, challenge systems, and shift power, not just improve access.
5
5
193